Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Danielle Sawyer & Kathryn Gates. (2017) Severe lamotrigine toxicosis in a dog. Veterinary Medicine: Research and Reports 8, pages 27-30.
Read now
Read now
Marco A Grados, Elizabeth B Atkins, Gabriela I Kovacikova & Erin McVicar. (2015) A selective review of glutamate pharmacological therapy in obsessive–compulsive and related disorders. Psychology Research and Behavior Management 8, pages 115-131.
Read now
Read now
Dawn F. Ionescu, Jerrold F. Rosenbaum & Jonathan E. Alpert. (2015) Pharmacological approaches to the challenge of treatment-resistant depression. Dialogues in Clinical Neuroscience 17:2, pages 111-126.
Read now
Read now
Articles from other publishers (24)
Dar'ya Ivanovna Chizh, Elena Nikolaevna Obedkina & Tat'yana Anatol'evna Pavlova. (2022) LAMOTRIGINE FOR THE TREATMENT OF EPILEPSY WITH CONCOMITANT COGNITIVE, EMOTIONAL-VOLITIONAL AND BEHAVIORAL DISORDERS IN GIRLS. Ulyanovsk Medico-biological Journal:2, pages 52-60.
Crossref
Crossref
Sule Aydin, Zeynep Gul Yazici, Cansu Kilic, Birce Ercelen Ozozturk & Fatma Sultan Kilic. (2021) An overview of the behavioral, neurobiological and morphological effects of topiramate in rats exposed to chronic unpredictable mild stress. European Journal of Pharmacology 912, pages 174578.
Crossref
Crossref
Rebecca L Dean, Tahnee Marquardt, Claudia Hurducas, Styliani Spyridi, Annabelle Barnes, Rebecca Smith, Philip J Cowen, Rupert McShane, Keith Hawton, Gin S Malhi, John Geddes & Andrea Cipriani. (2021) Ketamine and other glutamate receptor modulators for depression in adults with bipolar disorder. Cochrane Database of Systematic Reviews 2021:10.
Crossref
Crossref
Bradley N. Gaynes, Linda Lux, Gerald Gartlehner, Gary Asher, Valerie Forman‐Hoffman, Josh Green, Erin Boland, Rachel P. Weber, Charli Randolph, Carla Bann, Emmanuel Coker‐Schwimmer, Meera Viswanathan & Kathleen N. Lohr. (2019) Defining treatment‐resistant depression. Depression and Anxiety 37:2, pages 134-145.
Crossref
Crossref
Jose Alfonso Ontiveros. 2019. Antidepressants - Preclinical, Clinical and Translational Aspects. Antidepressants - Preclinical, Clinical and Translational Aspects.
Kah Kheng Goh, Chun-Hsin Chen, Yi-Hang Chiu & Mong-Liang Lu. (2019) Lamotrigine augmentation in treatment-resistant unipolar depression: A comprehensive meta-analysis of efficacy and safety. Journal of Psychopharmacology 33:6, pages 700-713.
Crossref
Crossref
Matthew Hearing, Nicholas Graziane, Yan Dong & Mark J. Thomas. (2018) Opioid and Psychostimulant Plasticity: Targeting Overlap in Nucleus Accumbens Glutamate Signaling. Trends in Pharmacological Sciences 39:3, pages 276-294.
Crossref
Crossref
Simplice Harquin Foyet, Ioana-Miruna Balmus, Ngatanko Abaïssou Hervé Hervé, Asongalem Acha Emmanuel, Samson Guenne, Martin Kiendrebéogo & Alin Ciobica. (2017) Ethnopharmacological approaches in mood and anxiety disorders. The relevance of the oxidative stress status. Journal of Complementary and Integrative Medicine 14:2.
Crossref
Crossref
Uma A. Bhosale, Radha Yegnanarayan, Ankush Gupta, Priyank Shah & Shalini Sardesai. (2017) Comparative pre-emptive analgesic efficacy study of novel antiepileptic agents gabapentin, lamotrigine and topiramate in patients undergoing major surgeries at a tertiary care hospital: a randomized double blind clinical trial. Journal of Basic and Clinical Physiology and Pharmacology 28:1, pages 59-66.
Crossref
Crossref
Katharine Smith & Mary Jane Attenburrow. (2018) Ketamine: a novel antidepressant with a fast onset of action?. BJPsych Advances 22:4, pages 216-221.
Crossref
Crossref
Tayla L McCloud, Caroline Caddy, Janina Jochim, Jennifer M Rendell, Peter R Diamond, Claire Shuttleworth, Daniel Brett, Ben H Amit, Rupert McShane, Layla Hamadi, Keith Hawton & Andrea Cipriani. (2015) Ketamine and other glutamate receptor modulators for depression in bipolar disorder in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Caroline Caddy, Ben H Amit, Tayla L McCloud, Jennifer M Rendell, Toshi A Furukawa, Rupert McShane, Keith Hawton & Andrea Cipriani. (2015) Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Andre F. Carvalho, Michael Berk, Thomas N. Hyphantis & Roger S. McIntyre. (2014) The Integrative Management of Treatment-Resistant Depression: A Comprehensive Review and Perspectives. Psychotherapy and Psychosomatics 83:2, pages 70-88.
Crossref
Crossref
Herng‐Nieng ChanPhilip B MitchellColleen K A LooSamuel B Harvey. (2013) Pharmacological treatment approaches to difficult‐to‐treat depression. Medical Journal of Australia 199:S6.
Crossref
Crossref
Charlotte L. Allan, Anya Topiwala, Klaus P. Ebmeier, David Semple & Douglas Steele. 2013. The Wiley-Blackwell Handbook of Mood Disorders. The Wiley-Blackwell Handbook of Mood Disorders
143
172
.
Chia-Ming Chang, Soichiro Sato & Changsu Han. (2013) Evidence for the Benefits of Nonantipsychotic Pharmacological Augmentation in the Treatment of Depression. CNS Drugs 27:S1, pages 21-27.
Crossref
Crossref
Siegfried Kasper & Stuart MontgomeryRobert Haußmann & Michael Bauer. 2013. Treatment‐resistant Depression. Treatment‐resistant Depression
129
157
.
Ross J. BaldessariniRoss J. Baldessarini. 2013. Chemotherapy in Psychiatry. Chemotherapy in Psychiatry
89
154
.
Carmen Andreescu & Charles F. Reynolds. (2012) Depresión a una edad avanzada: tratamiento basado en la evidencia y nuevos caminos prometedores para la investigación y la práctica clínica. Psiquiatría Biológica 19:4, pages 116-126.
Crossref
Crossref
Helena M. Abelaira, Gislaine Z. Réus, Karine F. Ribeiro, Giovanni Zappellini, Andreza L. Cipriano, Giselli Scaini, Emilio L. Streck & João Quevedo. (2012) Lamotrigine treatment reverses depressive-like behavior and alters BDNF levels in the brains of maternally deprived adult rats. Pharmacology Biochemistry and Behavior 101:3, pages 348-353.
Crossref
Crossref
Jose de Leon. 2012. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities. A Practitioner's Guide to Prescribing Antiepileptics and Mood Stabilizers for Adults with Intellectual Disabilities
155
184
.
Michele Fornaro, Matteo Martino, Bruna Dalmasso, Salvatore Colicchio, Marzia Benvenuti, Giulio Rocchi, Andrea Escelsior & Giulio Perugi. (2011) An open pilot study of zonisamide augmentation in major depressive patients not responding to a low dose trial with duloxetine: preliminary results on tolerability and clinical effects. Annals of General Psychiatry 10:1.
Crossref
Crossref
Carmen Andreescu & Charles F. ReynoldsIIIIII. (2011) Late-life Depression: Evidence-based Treatment and Promising New Directions for Research and Clinical Practice. Psychiatric Clinics of North America 34:2, pages 335-355.
Crossref
Crossref
Arash Mowla & Ehsan Kardeh. (2011) Topiramate augmentation in patients with resistant major depressive disorder: A double-blind placebo-controlled clinical trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry 35:4, pages 970-973.
Crossref
Crossref